With our combination of medical expertise, advanced technology, and a compassionate team, you receive a complete transformation experience, not just a treatment
This is not dangerous, but it may limit your results
Eli Lilly said Thursday that its triple-agonist obesity drug retatrutide hit every primary and key secondary endpoint in TRIUMPH-1, the Phase 3 registration trial that will anchor the company's expected FDA filing
In this article, we explore how metabolism is regulated , highlight the key cellular players , and introduce the tools developed by Axxam to study these mechanisms, focusing in particular on the GLP-1 (glucagon-like peptide-1) receptor assay
Significant reductions were observed for K-18 with the 8 mg and 12 mg doses of retatrutide (up to 49.6%) and for pro-C3 with all doses of retatrutide (up to 26.4%)
Whether you are interested in the convenience of a daily pill or the high-efficacy results of traditional GLP-1 weight loss injections, MTCs comprehensive approach ensures your treatment matches your lifestyle and metabolic needs